AR008675A1 - USE OF 8,9-DEHYDROESTRONE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF MOTOR VESSEL SYMPTOMS - Google Patents

USE OF 8,9-DEHYDROESTRONE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF MOTOR VESSEL SYMPTOMS

Info

Publication number
AR008675A1
AR008675A1 ARP970104747A ARP970104747A AR008675A1 AR 008675 A1 AR008675 A1 AR 008675A1 AR P970104747 A ARP970104747 A AR P970104747A AR P970104747 A ARP970104747 A AR P970104747A AR 008675 A1 AR008675 A1 AR 008675A1
Authority
AR
Argentina
Prior art keywords
dehydroestrone
manufacture
symptoms
treatment
medicinal product
Prior art date
Application number
ARP970104747A
Other languages
Spanish (es)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR008675A1 publication Critical patent/AR008675A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invencion procee el uso de 8,9-dehidroestrona o una sal farmacéuticamente aceptable de su ésster 3-sulfato para la manufactura de unmedicamento para tratar un mamífero en necesidad del mismo.This invention provides the use of 8,9-dehydroestrone or a pharmaceutically acceptable salt of its 3-sulfate ester for the manufacture of a drug to treat a mammal in need thereof.

ARP970104747A 1996-10-16 1997-10-15 USE OF 8,9-DEHYDROESTRONE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF MOTOR VESSEL SYMPTOMS AR008675A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73305196A 1996-10-16 1996-10-16

Publications (1)

Publication Number Publication Date
AR008675A1 true AR008675A1 (en) 2000-02-09

Family

ID=24946027

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104747A AR008675A1 (en) 1996-10-16 1997-10-15 USE OF 8,9-DEHYDROESTRONE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF MOTOR VESSEL SYMPTOMS

Country Status (4)

Country Link
AR (1) AR008675A1 (en)
AU (1) AU4756697A (en)
WO (1) WO1998016232A1 (en)
ZA (1) ZA979204B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481310A1 (en) * 2002-04-03 2003-10-16 Barr Laboratories, Inc. Step-down estrogen therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Also Published As

Publication number Publication date
ZA979204B (en) 1999-04-14
AU4756697A (en) 1998-05-11
WO1998016232A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
CO5011096A1 (en) MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS
CU23029A3 (en) BENZOPIRAN REPLACED ANALOGS FOR THE TREATMENT OF INFLAMMATION
ES2080307T3 (en) PHARMACEUTICAL COMPOSITIONS.
CY1107838T1 (en) ADAMANTANIUM PRODUCTION FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOGRAPHIC DISEASES
AR015940A1 (en) RAPAMYCIN DERIVATIVES CONTAINING TETRAZOL WITH SHORT MEDIUM LIVES AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
AR052774A1 (en) IMMUNOTHERAPY FOR AUTOIMMUNE DISORDERS
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
GT200600163A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
CY1105849T1 (en) USE OF ANTIseptics IN THE COMMERCIAL MANUFACTURE OF A PHARMACEUTICAL PREPARATION FOR THE PREVENTION OR TREATMENT OF INFLAMMATION WITHIN THE HUMAN BODY
AR019671A1 (en) USE OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF (+) NORCISAPRIDA OR A PHARMACOLOGICALLY ACCEPTABLE SALT OF THE SAME SUBSTANTIALLY FREE OF ITS (-) STEREOISOMERO, FOR THE PREPARATION OF A MEDICINAL PRODUCT
ES507236A0 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR TOPIC APPLICATION, USED IN THE TREATMENT OF ACNE.
AR019699A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DYSFUNCTION OF THE EVACUATION AND USE OF THE SAME FOR THE PREPARATION OF A THERAPEUTIC AGENT
NO995823D0 (en) Therapeutic agent for erectile dysfunction
BR0107493A (en) Substances for use in the treatment of psoriasis
ES2188995T3 (en) USE OF AN INHIBITOR OF THE H +, K + -ATPASA IN THE TREATMENT OF NASAL POLYPS.
PT1150704E (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
IT1290781B1 (en) ACTIVE THERAPEUTIC AGENT FOR THE TREATMENT OF NEURONAL DEGENERATIVE DISEASES.
AR008675A1 (en) USE OF 8,9-DEHYDROESTRONE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF MOTOR VESSEL SYMPTOMS
AR034142A1 (en) A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION
AR022348A1 (en) A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SYMPTOMS OF LOWER URINARY TRACT
AR002191A1 (en) ORAL PHARMACEUTICAL COMPOSITION OF PIPERIDINOALCANOL COMPOUNDS IN THE FORM OF SOLUTION, PROCEDURE FOR ITS PREPARATION
ES2191908T3 (en) 4-AMINOPIRROL (3,2-D) PYRIMIDINS AS ANTAGONISTS OF THE NEUROPEPTIDE RECEPTOR.
AR012638A1 (en) USE OF PREGNAN-3-OL-20-ONAS FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO PROVIDE PROGESTATIONAL THERAPY
NO20001894D0 (en) Use of TNF antagonists as drugs for the treatment of septic diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal